(Q84974486)
Statements
Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial) (English)
Anders Bruun Mathiasen
Erik Jørgensen
Abbas Ali Qayyum
Mandana Haack-Sørensen
1 September 2012